Update of the S3 guidelines for pancreatic cancer. What is new for pathologists?

被引：2
|
作者：
Munding, J. [1 ]
Luettges, J. [2 ]
Esposito, I. [3 ]
Tannapfel, A. [1 ]
机构：
[1] Ruhr Univ Bochum, Inst Pathol, Deutsch Mesotheliomregister, BG Univ Klinikum Bergmannsheil, D-44789 Bochum, Germany
[2] Marien Hosp, Inst Pathol, Hamburg, Germany
[3] Tech Univ Munich, Inst Pathol, Munich, Germany
来源：
PATHOLOGE | 2014年 / 35卷 / 05期
关键词：
Histopathology; Biopsy; Circumferential resection margin; Lymph node ratio; TNM staging; DUCTAL ADENOCARCINOMA; RESECTION MARGIN; R CLASSIFICATION; SURVIVAL; PANCREATICODUODENECTOMY; CARCINOMA; RELEVANCE; SURGERY; IMPACT;
D O I：
10.1007/s00292-012-1712-7
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
The S3 guidelines for pancreatic cancer were revised in 2013. Besides the oncological and palliative therapy modalities and surgical therapy, the guidelines for pathologists in topic 3 were updated. The modifications essentially concern the histopathological assessment of surgical specimens and in particular the circumferential resection margin and the R classification. In addition, the current recommendations were amended by recommendations concerning the pathohistological records, which should include the lymph node ratio in the future.
引用
收藏
页码：509 / 518
页数：10
相关论文
共 50 条
  • [1] Exocrine pancreatic cancer - what is new in the update of the S3 guideline?
    Seufferlein, Thomas
    Kestler, Angelika
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (12) : 737 - 743
  • [2] Update of the German S3 breast cancer guideline. What is new for pathologists?
    Lebeau, A.
    Denkert, C.
    Sinn, P.
    Schmidt, M.
    Woeckel, A.
    [J]. PATHOLOGE, 2019, 40 (02): : 185 - 198
  • [3] New S3 guidelines on exocrine pancreatic cancer
    Tannapfel, A.
    [J]. PATHOLOGE, 2012, 33 : 266 - 268
  • [4] What's new in the S3 guidelines for breast cancer
    Lebeau, A.
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 263 - 263
  • [5] Zusammenfassung – S3‑Leitlinien PankreaskarzinomSynopsis—S3 guidelines pancreatic cancer
    Christiane J. Bruns
    [J]. Der Chirurg, 2022, 93 (5): : 427 - 428
  • [6] Breast cancer: current recommendations for pathologists on the basis of the S3 guidelines
    Lebeau, A.
    Kreipe, H.
    Dietel, M.
    Schlake, W.
    Kreienberg, R.
    [J]. PATHOLOGE, 2013, 34 (04): : 293 - 304
  • [7] Update der S3-Leitlinie für das PankreaskarzinomWas ist neu für Pathologen?Update of the S3 guidelines for pancreatic cancerWhat is new for pathologists?
    J. Munding
    J. Lüttges
    I. Esposito
    A. Tannapfel
    [J]. Der Pathologe, 2014, 35 : 509 - 520
  • [8] WHO classification 2016 and first S3 guidelines on renal cell cancer. What is important for the practice?
    Moch, H.
    [J]. PATHOLOGE, 2016, 37 (02): : 127 - 133
  • [9] German S3 guidelines on bipolar disorders-first update 2019 What is new in pharmacotherapy?
    Bschor, T.
    Baethge, C.
    Grunze, H.
    Lewitzka, U.
    Scherk, H.
    Severus, E.
    Bauer, M.
    [J]. NERVENARZT, 2020, 91 (03): : 216 - 221
  • [10] Current amendments to the S3 guidelines on breast cancer. Surgical therapy
    Blohmer, J. -U.
    [J]. GYNAKOLOGE, 2012, 45 (06): : 438 - 442
12345